Immediate Impact
12 standout
Citing Papers
Bispecific antibodies: advancing precision oncology
2024 Standout
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
2024 Standout
Works of Max Beijert being referenced
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Max Beijert | 183 | 38 | 65 | 170 | 132 | 17 | 269 | |
| Réda Garidi | 98 | 41 | 62 | 94 | 90 | 15 | 252 | |
| Antonello Calderoni | 186 | 41 | 79 | 201 | 131 | 12 | 314 | |
| Sylvie Glaisner | 184 | 22 | 98 | 116 | 119 | 16 | 320 | |
| Jackline de Paula Ayres-Silva | 169 | 11 | 48 | 120 | 140 | 13 | 281 | |
| J Petit | 103 | 29 | 71 | 101 | 95 | 16 | 271 | |
| Giovanni Frezza | 167 | 56 | 100 | 103 | 62 | 16 | 321 | |
| Francisco Javier Peñalver | 128 | 48 | 46 | 110 | 139 | 13 | 305 | |
| Michaela Rancea | 228 | 77 | 141 | 88 | 69 | 11 | 287 | |
| Diana Libster | 183 | 72 | 116 | 59 | 69 | 16 | 294 | |
| Serafín Delgado | 220 | 33 | 149 | 122 | 56 | 12 | 324 |
All Works
Loading papers...